NICE enables groups and organisations to work together on their response to our online public consultations
New functionality for online collaboration on consultations, enables groups or organisations to submit a joined-up response.
New functionality for online collaboration on consultations, enables groups or organisations to submit a joined-up response.
Two exciting developments which will accelerate NICE’s efforts to deliver innovation to the health and care system faster.
The Innovative Licensing and Access Pathway (ILAP) will smooth the process by which innovative new medicines are developed, speeding their progression from clinical trial through to the NHS, bringing significant benefits to patients.
NICE has been part of a research project investigating how quality of life measures used to evaluate healthcare treatments such as drugs can be extended into areas of social care and public health.
The European Health Data and Evidence Network (EHDEN) project could support faster patient access to innovative medicines in areas of unmet need.
Following the successful evaluation of Zio XT, developers of digital health technologies are encouraged to engage with NICE through one of several different routes.
Page 10 of 11